Search

Author/Creator Berlanga, P.

1. Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience. (February 2021)

Authors:
Berlanga, P.; Pasqualini, C.; Pötschger, U.; Sangüesa, C.; Castellani, M.R.; Cañete, A.; Luksch, R.; Elliot, M.; Schreier, G.; Kropf, M.; Morgenstern, D.; Papadakis, V.; Ash, S.; Ruud, E.; Brock, P.; Wieczorek, A.; Kogner, P.; Trahair, T.; Ambros, P.; Boterberg, T.
Journal:
European journal of cancer
Issue:
Volume 144(2021)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population. (December 2016)

Authors:
Fischer, M.; Wulff, B.; Baruchel, S.; Berlanga, P.; Trahair, T.; Mechinaud, F.; Schulte, J.; Modak, S.; Merks, J.H.; Zwaan, C.M.; Marshall, L.V.; Casanova, M.; Branle, F.; Malet, I.; Emeremni, A.C.; Geoerger, B.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search